Chronic inflammatory demyelinating polyneuropathy (CIDP) is the chronic variant of Guillain-Barre Syndrome (GBS). Like the other variants of GBS, CIDP has been identified as a potential risk for individuals receiving tetanus and influenza vaccinations. This fact sheet provides an overview of important information for people who are preparing to be vaccinated or who have recently been diagnosed with CIDP.
If you or someone you love has been diagnosed with CIDP, it is important to understand how CIDP affects the body and what options are available for treating and managing the symptoms of this debilitating disorder. This fact sheet is intended to serve as a resource for individuals coping with CIDP.
What is CIDP?
CIDP is a neurological disorder that occurs when the body’s immune system attacks the myelin sheath protecting the peripheral nerves. It is also commonly known as chronic relapsing polyneuropathy. CIDP is most commonly characterized by weakness, sensory loss and loss of reflexes, though individuals diagnosed with the disorder also may experience a wide range of other symptoms.
What Causes CIDP?
Like other forms of GBS, the exact cause of CIDP remains unknown. However, the effects of the disorder result from the immune system’s attack on the nervous system, which can in turn lead to respiratory failure and other potentially serious complications.
Can I Get CIDP From a Vaccination?
Yes. A recognized link exists between all forms of GBS (including CIDP) and the vaccinations for tetanus and influenza. As a result of this link, many individuals diagnosed with CIDP and other forms of GBS following these vaccinations have been successful in securing financial compensation through the National Vaccine Injury Compensation Program (VICP).
How Common is CIDP?
CIDP is rare. There are fewer than 20,000 cases of GBS in the United States each year, and only a small portion of these cases involve diagnoses of CIDP.
Who is Most Likely to Get CIDP?
While anyone can get CIDP, the National Institute of Neurological Disorders and Stroke states that CIDP is most common among young adults and that men are more likely than women to be diagnosed with the disorder.
How is CIDP Diagnosed?
CIDP can be diagnosed through a variety of different tests, with electromyography (EMG) and spinal fluid analysis being among the most common. Because the effects of CIDP can also be symptomatic of other disorders, a thorough differential diagnosis is critical to ensure appropriate treatment and the best possible chance at recovery.
What is the Prognosis for Individuals Diagnosed with CIDP?
The prognosis for individuals diagnosed with CIDP depends on a number of factors, including how quickly treatment begins. Some patients can fully recover from their symptoms, while others may experience relapses or even permanent residual effects.
GBS Vaccine Lawyer | Legal Representation for Individuals Diagnosed with CIDP
GBS Vaccine Lawyer is a national law practice devoted to helping individuals and families recover financial compensation for vaccine-related illnesses. To learn more about how to seek financial compensation for CIDP, please call (202) 775-9200 or inquire online for a free consultation.